Oncology - ONCEPT Vaccine
The Technology Behind ONCEPT Vaccine and How it Works:
ONCEPT is the first DNA-based vaccine to aid in extending survival time in dogs treated for Canine Oral Melanoma.
The challenge with many cancers is that the host does not recognize the tumor as foreign, so the immune system is not elicited to defend the body against the tumor-producing cells.
ONCEPT is produced with xenogeneic plasmid DNA containing canine DNA for human tyrosinase (huTyr). This results in the production of a human antigen that is homologous to canine tyrosinase (cTyr), but recognized as foreign.
ONCEPT has demonstrated it is a safe, effective adjunct therapy that can significantly prolong survival times in dogs with stage II or III Canine Oral Melanoma for which local disease control has been achieved by traditional means.
Since 2007, thousands of dogs have been treated with a therapeutic vaccine following surgical removal of primary canine oral melanoma tumors. This innovative vaccine is fully licensed by the USDA and is available for treatment on Canine Melanoma.
ONCEPT is the first DNA-based vaccine to aid in extending survival time in dogs treated for Canine Oral Melanoma.
The challenge with many cancers is that the host does not recognize the tumor as foreign, so the immune system is not elicited to defend the body against the tumor-producing cells.
ONCEPT is produced with xenogeneic plasmid DNA containing canine DNA for human tyrosinase (huTyr). This results in the production of a human antigen that is homologous to canine tyrosinase (cTyr), but recognized as foreign.
ONCEPT has demonstrated it is a safe, effective adjunct therapy that can significantly prolong survival times in dogs with stage II or III Canine Oral Melanoma for which local disease control has been achieved by traditional means.
Since 2007, thousands of dogs have been treated with a therapeutic vaccine following surgical removal of primary canine oral melanoma tumors. This innovative vaccine is fully licensed by the USDA and is available for treatment on Canine Melanoma.
ONCEPT VaccineONCEPT News Release
Client Brochure
|
| ||||
Pasadena Pets Veterinary Hospital | 2850 East Foothill Blvd. | Pasadena, Ca 91107 | Ph: (626) 568-1115
Copyright © 2012 Pasadena Pets Hospital
Copyright © 2012 Pasadena Pets Hospital